A phase 2, proof of concept trial of NN-9828 in patients with hidradenitis suppurativa
Latest Information Update: 23 Feb 2026
At a glance
- Drugs Anti-interleukin-21 monoclonal antibody (Primary)
- Indications Hidradenitis suppurativa
- Focus Proof of concept; Therapeutic Use
Most Recent Events
- 23 Feb 2026 New trial record